Skip to Content
Find More Like This
Return to Search

Streptavidin mutants

United States Patent

6,022,951
February 8, 2000
View the Complete Patent at the US Patent & Trademark Office
The present invention relates to streptavidin proteins and peptides having a altered physical properties such as an increased stability or increased or decreased affinity for binding biotin. The invention also relates to methods for the detection, identification, separation and isolation of targets using streptavidin proteins or peptides. Streptavidin with increased or reduced affinity allows for the use of the streptavidin-biotin coupling systems for detection and isolation systems wherein it is necessary to remove of one or the other of the binding partners. Such systems are useful for the purification of functional proteins and viable cells. The invention also relates to nucleic acids which encode these streptavidin proteins and peptides and to recombinant cells such as bacteria, yeast and mammalian cells which contain these nucleic acids.
Sano; Takeshi (Boston, MA), Cantor; Charles R. (Boston, MA), Vajda; Sandor (Medfield, MA), Reznik; Gabriel O. (Boston, MA), Smith; Cassandra L. (Boston, MA), Pandori; Mark W. (San Diego, CA)
08/ 628,540
April 10, 1996
RIGHTS IN THE INVENTION This invention was made with United States Government support under grant number DE-FG02-93ER61656, awarded by the United States Department of Energy, and grant number CA39782, awarded by the National Cancer Institute, and the United States Government has certain rights in the invention.